Home / Pharmaceutical / The Pharmaceutical Market: South Africa

The Pharmaceutical Market: South Africa

Published: Jul 2014 | No Of Pages: 126 | Published By: Espicom

Product Synopsis

 
OVERVIEW OF THE PHARMACEUTICAL MARKET IN SOUTH AFRICA
 
The government drive to support local production and reduce the country's reliance on imports, in addition to global epidemiological and demographic trends, are all positive factors contributing to long-term growth in the pharmaceutical market. However, deep segregation between private and public healthcare facilities continues to leave the vast majority of the population without medical care. BMI believes this will be rectified through the creation of the National Health Insurance scheme over the next decade, but in the meantime unemployment, lack of education and geographical inaccessibility to healthcare for the wider population will continue to hinder growth in the market.
 
Headline Expenditure Projections
 
  • Pharmaceuticals: ZAR27.19bn (US$3.74bn) in 2011 to ZAR29.61bn (US$3.61bn) in 2012; +8.9% in local currency and -3.5% in US dollar terms.
  • Healthcare: ZAR261.51bn (US$36.01bn) in 2011 to ZAR285.26bn (US$34.79bn) in 2012; +9.1% in local currency terms and -3.4% in US dollar terms.
  • Medical devices: ZAR11.43bn (US$1.57bn) in 2011 to ZAR12.19bn (US$1.49bn) in 2012; +6.7% in local currency terms and -5.5% in US dollar terms. Forecast changed due to depreciation of the South African rand.
Risk/Reward Rating
 
South Africa's composite score is unchanged at 55.5 out of 100, with no shift in position at sixth in the matrix out of 30 markets surveyed in the Middle East and Africa. Despite the country's low risk profile being more favourable than its rewards profile, the country remains one of the most attractive in the MEA region.
 
Competitive Landscape
 
The competitive landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales - for the total pharmaceutical sector, as well as the OTC, generics, and distribution sub-sectors.
BMI Industry View7
BMI Industry View7
SWOT9
Political11
Economic12
Business Environment13
Industry Forecast14
Pharmaceutical Market Forecast14
Table: South Africa Pharmaceutical Sales, Historical Data And Forecasts15
 
Healthcare Market Forecast16

Table: South Africa Healthcare Expenditure Trends, Historical Data And Forecasts17
Table: South Africa Government Healthcare Expenditure Trends, Historical Data And Forecasts18
Table: South Africa Private Healthcare Expenditure Trends, Historical Data And Forecasts18
 
Prescription Drug Market Forecast19
 
Table: South Africa Prescription Drug Market Indicators, Historical Data And Forecasts20
 
Patented Drug Market Forecast20
 
Table: South Africa Patented Drug Market Indicators, Historical Data And Forecasts21
 
Generic Drug Market Forecast22
 
Table: South Africa Generic Drugs Market Indicators, Historical Data And Forecasts24
 
OTC Medicine Market Forecast24
 
Table: South Africa Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts26
 
Pharmaceutical Trade Forecast27
 
Table: South Africa Pharmaceutical Trade Data And Forecasts (US$mn)28
Table: South Africa Pharmaceutical Trade Data And Forecasts (ZARmn)28
 
Other Healthcare Data29
Key Risks To BMI's Forecast Scenario29
Macroeconomic Forecasts31
Economic Analysis31
 
Table: South Africa - Real GDP Growth31
Table: South Africa - Economic Activity36
 
Industry Risk Reward Ratings37
Risk/Reward Ratings37
 
Table: Middle East And Africa Pharmaceutical Risk/Reward Ratings, Q21337
 
Rewards39
Risks39
Market Overview41
Industry Trends And Developments43
Epidemiology43
Healthcare Sector47
National Health Insurance Scheme48
Public Healthcare Reform49
Private Healthcare Regulation51
National Health Reference Price List53
Government Health Insurance53
Healthcare Infrastructure54
 
Table: Public Sector Hospitals By Province 2004-201155
Table: Private Hospitals By Province 2004-201055
Table: Public Sector Hospital Beds By Province, 2005-200956
Table: Private Sector Hospital Beds By Province, 1998-201057
 
Research & Development Sector57
Clinical Trials60
Vaccines61
Traditional African Medicine61
Regulatory Development63
Regulatory Regime63
 
Table: Drug Classification System63
 
Regulatory Developments66
Intellectual Property Environment66
Pricing Regime67
 
Table: Tiered Pharmaceutical Pricing System Is Better Than A Flat Fixed Mark-Up68
Table: SEP Inflation, 2008-201169
 
Reimbursement Regime70
Competitive Landscape72
Pharmaceutical Sector72
Pharmaceutical Sector Developments74
Pharmaceutical Retail Sector77
Company Profile81
Aspen Pharmacare81
Adcock Ingram86
Cipla Medpro89
Ranbaxy92
Sanofi95
Pfizer98
Roche100
GlaxoSmithKline102
Merck & Co106
Novartis108
Demographic Forecast110
Demographic Outlook110
 
Table: South Africa's Population By Age Group, 1990-2020 ('000)111
Table: South Africa's Population By Age Group, 1990-2020 (% of total)112
Table: South Africa's Key Population Ratios, 1990-2020113
Table: South Africa's Rural And Urban Population, 1990-2020113
 
Glossary114
Methodology116
Methodology116
Pharmaceutical Expenditure Forecast Model116
Healthcare Expenditure Forecast Model116
Notes On Methodology117
Risk/Reward Ratings Methodology118
Ratings Overview119
 
Table: Pharmaceutical Risk/Reward Ratings Indicators119
 
Indicator Weightings120
Choose License Type
 
Contact Information
24/7 Research Support
Phone: +1-855-455-8662
sales@acutemarketreports.com
Get in Touch with us
join us on Facebook
Follow us on Twitter
Follow us on LinkedIn
Add us on Google +